Articles From: Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib to Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Albany Molecular Research Inc.


Exelixis, Inc. (NASDAQ:EXEL) today announced preliminary results from a phase 1 investigator-sponsored trial (IST) evaluating the safety and activity of XL888, an Exelixis-discovered small molecule oral inhibitor of Heat Shock Protein 90 (HSP90), in combination with vemurafenib in patients with unresectable stage III/IV BRAF V600 mutation-positive melanoma.
Sign-up for Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib investment picks
2014/11/15
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Shrek will not join forces with Transformers.
Sign-up for Hasbro-DreamWorks merger talks break down investment picks
2014/11/15
The second annual UnitedHealthcare IRONKIDS Tempe Fun Run raced around Tempe Beach Park today.
Sign-up for UnitedHealthcare Teams Up with IRONKIDS for First Ever Special Needs Course investment picks
2014/11/15
Academy and GRAMMY Award winning artist Jennifer Hudson helps unwrap store and launch holiday season CHICAGO , Nov.
Sign-up for Verizon Wireless Unveils New Technology Destination on Chicago's Magnificent Mile investment picks
2014/11/15
The Estée Lauder brand today announced that it has signed Kendall Jenner, fashion’s new breakout star and social media sensation.
Sign-up for Estée Lauder Signs Model of the Moment and Social Media Phenomenon Kendall Jenner investment picks
2014/11/15
By Quentin Fottrell, MarketWatch Facebook (FB) Chief Executive Mark Zuckerberg dropped out of Harvard University, and yet became a billionaire before this 30th birthday.
Sign-up for UPDATE: 10 business schools that churn out billionaires investment picks
2014/11/15
By Quentin Fottrell, MarketWatch It's the fastest-growing online retail day of the year There's no need to worry about shoppers brandishing pepper spray this year: Black Friday is moving online.
Sign-up for UPDATE: Once a blood sport, Black Friday moves online investment picks
2014/11/15
By Quentin Fottrell, MarketWatch Once the purveyor of all things free and often the subject of copyright infringements due to consumers uploading videos, Google Inc.'s (GOOG) YouTube is starting a music subscription service for $9.99 a month, which is the same price as music-streaming services like Spotify.
Sign-up for UPDATE: 5 things that used to be free (but aren't anymore) investment picks
2014/11/15
By Quentin Fottrell, Catey Hill and Charles Passy, MarketWatch From airlines to cellphone carriers to restaurants, a number of businesses make bold, tantalizing promises of "unlimited" goods and services.
Sign-up for UPDATE: 6 unlimited offers that aren't actually unlimited investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers presented data from clinical trials of Soliris ® (eculizumab) in patients with atypical hemolytic uremic syndrome (aHUS), as well as an update from the Global aHUS Registry, at Kidney Week 2014, the annual meeting of the American Society of Nephrology, in Philadelphia.
Sign-up for Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment investment picks
2014/11/15
By Jake LingemanDrag Pack, Handling Pack and Super Pack added Ford's new King Cobra Mustang made its debut earlier this month at the SEMA Show in Las Vegas with a good bit of fanfare.
Sign-up for UPDATE: Ford reveals new King Cobra Mustang investment picks
2014/11/14
PORTERVILLE, Calif.
Sign-up for Sierra Bancorp Completes Santa Clara Valley Bank Aquisition investment picks
2014/11/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159216&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for TESCO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tesco PLC - TSCDY investment picks
2014/11/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159215&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for BANKRATE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Bankrate, Inc. - RATE investment picks
2014/11/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159214&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for LUMBER LIQUIDATORS 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Lumber Liquidators Holdings, Inc. - LL investment picks
2014/11/14
By Liz Hoffman and Alison Sider Halliburton Co.
Sign-up for UPDATE: Halliburton takes steps to unseat Baker Hughes board as bid takes hostile turn investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979293001&sourceType=1 http://media3.marketwire.com/logos/20140331-Klondike.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Klondex Files Technical Report in Relation to Its Midas Mine and Mill investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979291001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Reports 2014 Third Quarter Financial Results investment picks
2014/11/14
By Liz Hoffman and Alison Sider Halliburton Co.
Sign-up for Halliburton takes steps to unseat Baker Hughes board as bid turns hostile investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib to Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Albany Molecular Research Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent